Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NIH Grants Awarded to Epivax; Northwestern; and More

Premium

NIH Grants in Proteomics, June 8 to July 19, Part 1 of 2. (Part 2 is available here.)

Project Title: Salivary Biomarkers in the Diagnosis of BRONJ
Contact Principal Investigator: Tara Aghaloo
Organization Name: University of California Los Angeles
Project Start Date: July 1, 2011
Project End Date: June 30, 2014
FY Total Cost: $115,830


Project Title: Core C: Cell, Imaging and Proteomics Core
Contact Principal Investigator: Anirban Banerjee
Organization Name: University of Colorado Denver
Project Start Date: NA
Project End Date: NA
FY Total Cost: $438,447


Project Title: Overall Application: Trauma Primes Cells
Contact Principal Investigator: Anirban Banerjee
Organization Name: University of Colorado Denver
Project Start Date: April 1, 1997
Project End Date: May 31, 2016
FY Total Cost: $2,132,680


Project Title: A Universal Electromagnetostatic Tandem-Mass-Spectrometric Dissociation-Cell
Contact Principal Investigator: Douglas Barofsky
Organization Name: Oregon State University
Project Start Date: Sept. 10, 2010
Project End Date: June 30, 2015
FY Total Cost: $352,308


Project Title: Antigen Immunoassay for Diagnosis of Coccidioidomycosis
Contact Principal Investigator: Sean Bauman
Organization Name: Immuno-Mycologics
Project Start Date: July 1, 2012
Project End Date: June 30, 2014
FY Total Cost: $295,438


Project Title: CyTOF Mass Cytometer for Western New York
Contact Principal Investigator: Timothy Bushnell
Organization Name: University of Rochester
Project Start Date: July 13, 2012
Project End Date: July 12, 2013
FY Total Cost: $775,000


Project Title: Protein Kinase Signaling Pathways
Contact Principal Investigator: Lewis Cantley
Organization Name: Beth Israel Deaconess Medical Center
Project Start Date: July 1, 1997
Project End Date: June 30, 2013
FY Total Cost: $366,557


Project Title: Data Mining
Contact Principal Investigator: Damien Chaussabel
Organization Name: Baylor Research Institute
Project Start Date: NA
Project End Date: NA
FY Total Cost: $321,297


Project Title: Molecular & Functional Regulatory Network in Hypertension
Contact Principal Investigator: Allen Cowley
Organization Name: Medical College of Wisconsin
Project Start Date: NA
Project End Date: NA
FY Total Cost: $563,008


Project Title: Genetic & Physiological Basis of Salt-Sensitive Hypertension
Contact Principal Investigator: Allen Cowley
Organization Name: Medical College of Wisconsin
Project Start Date: Feb. 1, 2006
Project End Date: June 30, 2016
FY Total Cost: $2,269,275


Project Title: A Novel Proteomic Approach to TB Biomarker Discovery Using Human Exosomes
Contact Principal Investigator: John Davis
Organization Name: University of California San Francisco
Project Start Date: July 10, 2012
Project End Date: June 30, 2014
FY Total Cost: $222,750


Project Title: Novel H1N1 Influenza Protection via Cross-Reactive Immunity
Contact Principal Investigator: Anne Degroot
Organization Name: Epivax
Project Start Date: May 1, 2011
Project End Date: April 30, 2013
FY Total Cost: $250,758


Project Title: An Integrated Systems Biology Approach for Ovarian Cancer Biomarker Discovery
Contact Principal Investigator: Eleftherios Diamandis
Organization Name: Mt. Sinai Hospital-Samuel Lunenfeld Research Institute
Project Start Date: Sept. 1, 2010
Project End Date: June 30, 2015
FY Total Cost: $190,288


Project Title: Proteomics Shared Resource
Contact Principal Investigator: Brian Druker
Organization Name: Oregon Health and Science University
Project Start Date: NA
Project End Date: NA
FY Total Cost: $51,908


Project Title: Animal Model Resources for Cystic Fibrosis
Contact Principal Investigator: Mitchell Drumm
Organization Name: Case Western Reserve University
Project Start Date: July 1, 2011
Project End Date: June 30, 2015
FY Total Cost: $525,734


Project Title: Determinants of Efficacy to the Akt Inhibitor Perifosine in Colorectal Cancer
Contact Principal Investigator: Cathy Eng
Organization Name: University of Texas MD Anderson Cancer Center
Project Start Date: July 1, 2011
Project End Date: June 30, 2013
FY Total Cost: $103,095


Project Title: Fox Chase Clinical Epidemiology and Validation Center
Contact Principal Investigator: Paul Engstrom
Organization Name: Fox Chase Cancer Center
Project Start Date: March 21, 2005
Project End Date: June 30, 2015
FY Total Cost: $716,546


Project Title: Training Grant in Environmental Toxicology
Contact Principal Investigator: John Essigmann
Organization Name: Massachusetts Institute of Technology
Project Start Date: July 1, 1975
Project End Date: June 30, 2015
FY Total Cost: $501,833


Project Title: Real-Time Reagent-Free Noninvasive Diagnosis of Tuberculosis
Contact Principal Investigator: David Fergenson
Organization Name: Livermore Instruments
Project Start Date: July 1, 2012
Project End Date: June 30, 2014
FY Total Cost: $296,056


Project Title: Novel Antigen Identification for an Enterotoxigenic E. Coli Vaccine
Contact Principal Investigator: James Fleckenstein
Organization Name: Washington University
Project Start Date: July 1, 2010
Project End Date: June 30, 2015
FY Total Cost: $312,396


Project Title: Transcriptional Regulation, the Nuclear Proteome, and HIV/METH/CART
Contact Principal Investigator: Howard Fox
Organization Name: University of Nebraska Medical Center
Project Start Date: Sept. 17, 2010
Project End Date: June 30, 2015
FY Total Cost: $623,113


Project Title: SGK1 Signaling Pathways in Vascular Remodeling
Contact Principal Investigator: Sharon Francis
Organization Name: Morehouse School of Medicine
Project Start Date: Aug. 15, 2010
Project End Date: June 30, 2015
FY Total Cost: $280,170


Project Title: Tissue Bank and Biomarkers Core
Contact Principal Investigator: Wilbur Franklin
Organization Name: University of Colorado Denver
Project Start Date: NA
Project End Date: NA
FY Total Cost: $236,175


Project Title: Substance Use and Immunity in HIV+ Adolescents by Systems Biology
Contact Principal Investigator: Maureen Goodenow
Organization Name: University of Florida
Project Start Date: Sept. 17, 2010
Project End Date: June 30, 2015
FY Total Cost: $887,560


Project Title: Systematic Analysis of the DUB Proteome
Contact Principal Investigator: Jeffrey Harper
Organization Name: Harvard University Medical School
Project Start Date: May 1, 1996
Project End Date: June 30, 2013
FY Total Cost: $348,397


Project Title: Discovery and Targeting of HIV-1 Associated Antigens
Contact Principal Investigator: William Hildebrand
Organization Name: University of Oklahoma Health Sciences Center
Project Start Date: July 7, 2010
Project End Date: June 30, 2014
FY Total Cost: $509,781


Project Title: Biostatistics Core
Contact Principal Investigator: Sarah Holte
Organization Name: University of Washington
Project Start Date: NA
Project End Date: NA
FY Total Cost: $66,269


Project Title: Quantitative Analysis of the Evolving Genotype-to-Phenotype Map
Contact Principal Investigator: Daniel Jarosz
Organization Name: Whitehead Institute for Biomedical Research
Project Start Date: July 1, 2011
Project End Date: June 30, 2013
FY Total Cost: $88,581


Project Title: Polynucleotide High Performance Affinity Chromatography
Contact Principal Investigator: Harry Jarrett
Organization Name: University of Texas San Antonio
Project Start Date: Aug. 1, 1989
Project End Date: June 30, 2014
FY Total Cost: $297,455


Project Title: Mass Spectrometric Studies of Thiotemplate Biosynthesis
Contact Principal Investigator: Neil Kelleher
Organization Name: Northwestern University at Chicago
Project Start Date: May 1, 2003
Project End Date: June 30, 2014
FY Total Cost: $292,220


Project Title: Protein Aggregation and Inclusion Body Formation
Contact Principal Investigator: Ron Kopito
Organization Name: Stanford University
Project Start Date: July 1, 2012
Project End Date: June 30, 2017
FY Total Cost: $626,196

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.